Skip to main content

Intention to Treat and Alternative Approaches

  • Reference work entry
  • First Online:
Principles and Practice of Clinical Trials
  • 252 Accesses

Abstract

“Intention to treat” or “intent to treat” (ITT) is the principal approach for the evaluation of the treatment or intervention effect in a randomized clinical trial (RCT). In an RCT, patients or subjects are randomized to one or more study interventions according to a formal protocol that describes the entry criteria, study treatments, follow-up plans, and statistical analysis approaches. In an ideal trial, all randomized patients or subjects have the correct diagnosis, are randomized correctly, comply with the treatment, and are evaluated according to the study plan. These patients would have complete data and follow-up. In this case, the ITT analysis that respects the randomization principle provides unbiased tests of the null hypothesis that there is no treatment or intervention effect. The goal in many cases is to establish the efficacy of a treatment or intervention: does the planned treatment work? In practice, however, because of the many ways in which the ideal is not the reality, an ITT analysis provides a comparative evaluation of the effectiveness of the randomized intervention strategy (does the strategy work), rather than of the efficacy of the planned intervention itself. Examples of blinded, unblinded, screening, and drug clinical trials are provided. Approaches to handling deviations from ideal are described.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 499.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 599.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Almirall D, Nahum-Shani I, Sherwood NE, Murphy SA (2014) Introduction to SMART designs for the development of adaptive interventions: with application to weight loss research. Transl Behav Med 4:26–274. PMCID: PMC4167891

    Article  Google Scholar 

  • Begg CB (2000) Commentary: ruminations on the intent-to-treat principle. Control Clin Trials 21:241–243

    Article  Google Scholar 

  • Belitskaya-Levy I, Shao Y, Goldberg JD (2008) Systematic missing-at-random (SMAR) design and analysis for translational research studies. Int J Biostat 4(1):Article 15. https://doi.org/10.2202/1557-4679.1046. PubMed PMID: 20231908; PubMed Central PMCID: PMC2835456

    Article  MathSciNet  Google Scholar 

  • Bell ML, Fiero M, Horton NJ, Hsu C-H (2014) Handling missing data in RCTs; a review of the top medical journals. BMC Med Res Methodol 14:118

    Article  Google Scholar 

  • Berk PD, Goldberg JD, Silverstein MN et al (1981) Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy. NEJM 304:441–447

    Article  Google Scholar 

  • Berk PD, Wasserman LR, Fruchtman SM, Goldberg JD (1995) Treatment of polycythemia vera; a summary of clinical trials conducted by the polycythemia vera study group. In: Wasserman LR, Berk PD (eds) Polycythemia vera and the myeloproliferative disorders. Chapter 15. N. Saunders, Berlin, pp 166–194

    Google Scholar 

  • Brownlee KA (1955) Statistics of the 1954 polio vaccine trials. J Am Stat Assoc 50(272):1005–1013

    Google Scholar 

  • DeMets DL (2004) Statistical issues in interpreting clinical trials. J Intern Med 255:529–537

    Article  Google Scholar 

  • Ellenberg J (1996) Intent-to-treat analysis vs as-treated analysis. Drug Inf J 30:535–544

    Article  Google Scholar 

  • Ellenberg J (2005) Intention to treat analysis: basic. Encyclopedia of biostatistics. John Wiley and Sons, Ltd

    Google Scholar 

  • Fink R, Shapiro S, Lewison J (1968) The reluctant participant in a breast cancer screening program. Public Health Rep 83(6):479–490

    Article  Google Scholar 

  • Fragakis CE, Rubin DB (2002) Principal stratification in causal inference. Biometrics 58:21–29

    Article  MathSciNet  Google Scholar 

  • Francis T Jr et al (1955) An evaluation of the 1954 poliomyelitis vaccine trials – summary report. Am J Public Health 45(5):1–63

    Google Scholar 

  • Friedman LM, Furberg CD, DeMets DL (1998) Fundamentals of clinical trials, 3rd edn. Springer, New Year

    Book  Google Scholar 

  • Goetghebuer E, Loeys T (2002) Beyond intention to treat. Epidemiol Rev 24:85–90

    Article  Google Scholar 

  • Goldberg JD (1975) The effects of misclassification on the bias in the difference between two proportions and the relative odds in the fourfold table. J Am Stat Assoc 70:561–567

    Google Scholar 

  • Goldberg JD (2006) The changing role of statistics in medical research: experiences from the past and directions for the future. Invited paper, Proc Amer Stat Assoc. 1963–1969

    Google Scholar 

  • Goldberg JD, Belitskaya-Levy I (2008a) In: Melnick E, Everitt BS (eds) Intent-to-treat principle. Encyclopedia of quantitative risk assessment. Wiley, Chichester

    Google Scholar 

  • Goldberg JD, Belitskaya-Levy I (2008b) In: Melnick E, Everitt BS (eds) Randomized controlled trials. Encyclopedia of quantitative risk assessment. Wiley, Chichester

    Google Scholar 

  • Goldberg JD, Belitskaya-Levy I (2008c) In: Melnick E, Everitt BS (eds) Efficacy. Encyclopedia of quantitative risk assessment. Wiley, Chichester

    Google Scholar 

  • Goldberg JD, Koury KJ (1989) In: Berry DA (ed) Design and analysis of multicenter trials. Chapter 7 in statistical methodology in the pharmaceutical sciences. Marcel Dekker, New York, pp 201–237

    Google Scholar 

  • Goldberg JD, Shao YS (2008) In: Melnick E, Everitt BS (eds) Comparative efficacy trials (phase III studies). Encyclopedia of quantitative risk assessment. Wiley, Chichester

    Google Scholar 

  • Harrington DB (2000) The randomized clinical trial. J Am Stat Assoc 95:312–315

    Article  Google Scholar 

  • Hogan JW, Roy J, Korkontzelou C (2004) Tutorial in biostatistics: handling drop-out in longitudinal studies. Stat Med 23:1455–1497

    Article  Google Scholar 

  • ICH (1998) E9: guideline on statistical principles for clinical trials. www.ich.org

  • ICH (2017) E9 R1: Addendum on estimands and sensitivity analyses in clinical trials. Step 2. www.ich.org

  • Kim MY, Goldberg JD (2001) The effects of outcome misclassification and measurement error on the design and analysis of therapeutic equivalence trials. Stat Med 20(14):2065–2078. PubMed PMID: 1143942

    Article  Google Scholar 

  • Lachin JM (2000) Statistical considerations in the intent-to-treat principle. Control Clin Trials 21:167–189

    Article  Google Scholar 

  • Little R, Kang S (2015) Intention-to-treat analysis with treatment discontinuation and missing data in clinical trials. Stat Med 34:2381–2390

    Article  MathSciNet  Google Scholar 

  • Little RJA, Rubin DB (2000) Casual effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches. Annu Rev Public Health 21:121–145

    Article  Google Scholar 

  • Little RJA, Long Q, Lin X (2009) A comparison of methods for estimating the causal effects of a treatment in randomized clinical trials subject to noncompliance. Biometrics 65:640–649

    Article  MathSciNet  Google Scholar 

  • Mascarenhas J et al (2018) Results of the myeloproliferative neoplasms – research consortium (MPN-RC) 112 randomized trial of pegylated interferon alfa-2a (PEG) versus hydroxyurea (HU) therapy for the treatment of high risk polycythemia vera (PV) and high risk essential thrombocythemia (ET). Blood 132:577. https://doi.org/10.1182/blood-2018-99-111946

    Article  Google Scholar 

  • Meier P (1957) Safety testing of poliomyelitis vaccine. Science 125:1067–1071. https://doi.org/10.1126/science.125.3257

    Article  Google Scholar 

  • Meier P (1989) The biggest public health experiment ever: the 1954 field trial of the Salk poliomyelitis vaccine. In: Tanur JM, Mosteller F, Kruskal WH, Lehmann EL, Link RF, Pieters RS, Rising GR (eds) Statistics: a guide to the unknown, 3rd edn. Duxbury

    Google Scholar 

  • National Research Council (2010) The prevention and treatment of missing data in clinical trials. The National Academies Press, Washington, DC

    Google Scholar 

  • Piantadosi S (1997) Clinical trials: a methodologic perspective. Wiley-Interscience, New York

    MATH  Google Scholar 

  • Royes J, Sims J, Ogollah R, Lewis M (2015) A systematic review finds variable use of the intention-to-treat principle in musculoskeletal randomized controlled trials with missing data. J Clin Epidemiol 68:15–24

    Article  Google Scholar 

  • Sanchez MM, Chen X (2006) Choosing the analysis population in non-inferiority studies. Stat Med 25:1169–1181

    Article  MathSciNet  Google Scholar 

  • Shaffer M, Chinchilli V (2004) Bayesian inferences for randomized clinical trials with treatment failures. Stat Med 23:1215–1228

    Article  Google Scholar 

  • Shapiro S, Goldberg JD, Hutchison GB (1974) Lead time in breast cancer detection and implications for periodicity of screening. Am J Epidemiol 100(5):357–366. PubMed PMID: 4417355

    Article  Google Scholar 

  • Shapiro S, Venet W, Strax P, Venet L (1988) Periodic screening for breast cancer: the health insurance plan project and its sequelae, 1963–1986. Johns Hopkins, Baltimore

    Google Scholar 

  • Stuart EA, Perry DF, Le H-N, Ialongo NS (2008) Estimating intervention effects of prevention programs: accounting for noncompliance. Prev Sci 9:288–298

    Article  Google Scholar 

  • Thabane L, Mbuagbaw L, Zhang S, Samaan Z, Marcucci M, Ye C, Thabane M, Giangregorio L, Dennis B, Kosa D, Debana VB, Dillenburg R, Fruci V, Bawor M, Lee J, Wells G, Goldsmith CH (2013) A tutorial on sensitivity analyses in clinical trials: the what, why, when and how. BMC Med Res Methodol 13:92. http://www.biomedcentral.com/1471-2288/13/92. Accessed 28 Apr 2018

    Article  Google Scholar 

  • US FDA (2016) Non-inferiority clinical trials to establish effectiveness: guidance for industry. https://www.fda.gov/downloads/Drugs/Guidances/UCM202140

  • Van der Laan MJ, Petersen ML (2007) Causal effect models for realistic individualized treatment and intention to treat rules. Int J Biostat 3(1):Article 3. http://www.bepress.com/ijb/vol3/iss1/3

    MathSciNet  MATH  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Judith D. Goldberg .

Editor information

Editors and Affiliations

Section Editor information

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Goldberg, J.D. (2022). Intention to Treat and Alternative Approaches. In: Piantadosi, S., Meinert, C.L. (eds) Principles and Practice of Clinical Trials. Springer, Cham. https://doi.org/10.1007/978-3-319-52636-2_113

Download citation

Publish with us

Policies and ethics